Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (141-150 of 387) with videos related to

Pageof 39
Sort By:
Journal of the American Academy of Dermatology|December 21, 2024
Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension studyYuji Yamaguchi, Elena Peeva, Roni Adiri, et al.
Dermatology and Therapy|February 2, 2020
Qualitative Assessment of Adult Patients' Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional StudyBruno Falissard, Eric L Simpson, Emma Guttman-Yassky, et al.
Experimental Dermatology|December 15, 2015
Biomarkers of alopecia areata disease activity and response to corticosteroid treatmentJudilyn Fuentes-Duculan, Nicholas Gulati, Kathleen M Bonifacio, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2021
Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsetsJaehwan Kim, Jongmi Lee, Hyun Je Kim, et al.
The Journal of Investigative Dermatology|November 10, 2016
An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the DiseaseBenjamin Ungar, Sandra Garcet, Juana Gonzalez, et al.
Dermatology and Therapy|November 12, 2024
Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b StudyMelinda Gooderham, Emma Guttman-Yassky, Ken Igawa, et al.
Dermatology and Therapy|March 6, 2020
Correction to: Qualitative Assessment of Adult Patients' Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional StudyBruno Falissard, Eric L Simpson, Emma Guttman-Yassky, et al.
Molecular Psychiatry|February 11, 2026
Major depressive disorder shares systemic immune signatures and potential therapeutic targets with inflammatory skin diseasesHelen He, Flurin Cathomas, Lyonna F Parise, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2010
Characterisation of the cutaneous pathology in non-small cell lung cancer (NSCLC) patients treated with the EGFR tyrosine kinase inhibitor erlotinibEmma Guttman-Yassky, Alain Mita, Maja De Jonge, et al.
The Journal of Allergy and Clinical Immunology|November 10, 2009
Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genesLisa C Zaba, Mayte Suárez-Fariñas, Judilyn Fuentes-Duculan, et al.
Pageof 39

Showing results (141-150 of 387) with videos related to

Sort By:
Pageof 39
Journal of the American Academy of Dermatology|December 21, 2024
Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension studyYuji Yamaguchi, Elena Peeva, Roni Adiri, et al.
Dermatology and Therapy|February 2, 2020
Qualitative Assessment of Adult Patients' Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional StudyBruno Falissard, Eric L Simpson, Emma Guttman-Yassky, et al.
Experimental Dermatology|December 15, 2015
Biomarkers of alopecia areata disease activity and response to corticosteroid treatmentJudilyn Fuentes-Duculan, Nicholas Gulati, Kathleen M Bonifacio, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2021
Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsetsJaehwan Kim, Jongmi Lee, Hyun Je Kim, et al.
The Journal of Investigative Dermatology|November 10, 2016
An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the DiseaseBenjamin Ungar, Sandra Garcet, Juana Gonzalez, et al.
Dermatology and Therapy|November 12, 2024
Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b StudyMelinda Gooderham, Emma Guttman-Yassky, Ken Igawa, et al.
Dermatology and Therapy|March 6, 2020
Correction to: Qualitative Assessment of Adult Patients' Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional StudyBruno Falissard, Eric L Simpson, Emma Guttman-Yassky, et al.
Molecular Psychiatry|February 11, 2026
Major depressive disorder shares systemic immune signatures and potential therapeutic targets with inflammatory skin diseasesHelen He, Flurin Cathomas, Lyonna F Parise, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2010
Characterisation of the cutaneous pathology in non-small cell lung cancer (NSCLC) patients treated with the EGFR tyrosine kinase inhibitor erlotinibEmma Guttman-Yassky, Alain Mita, Maja De Jonge, et al.
The Journal of Allergy and Clinical Immunology|November 10, 2009
Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genesLisa C Zaba, Mayte Suárez-Fariñas, Judilyn Fuentes-Duculan, et al.
Pageof 39